Objective: To assess the natural history of congenital myopathies (CMs) due to different genotypes. Methods: Retrospective cross-sectional study based on case-note review of 125 patients affected by CM, followed at a single pediatric neuromuscular center, between 1984 and 2012.
phenotypes, whereas mutations in different genes may cause the same CM, often due to the similar function of the defective gene products. The need for comprehensive data regarding functional abilities, cardiorespiratory involvement, orthopedic complications, and survival, as a basis for anticipatory patient management and planning of future therapeutic trials, has been recently highlighted. 4 The natural history of specific subgroups has been described in only a few cohorts, not all of which had been fully genetically characterized. 5, [13] [14] [15] [16] [17] [18] [19] Herein, we report the clinical course of 125 patients with CM, reviewed at a single neuromuscular center. Furthermore, genotypephenotype correlations in a subgroup of 99 genetically characterized cases are illustrated. METHODS Patients. This was a retrospective cross-sectional study of cases with a diagnosis of CM. All patients had an evocative clinical picture (characterized by congenital/early childhood onset with hypotonia, static/progressive weakness, affecting predominantly proximal/axial muscles, normal/mildly elevated serum creatine kinase), at least one histopathologic feature suggestive of CM, and/or a genetic diagnosis. Data were obtained from the case notes of patients followed between 1984 and 2012 at the Dubowitz Neuromuscular Centre, London. We collected the following information: family history (consanguinity, miscarriages, premature deaths, ethnic origin), pregnancy (decreased fetal movements, oligohydramnios/polyhydramnios), birth (gestational age, delivery) and neonatal history (respiratory support, nasogastric tube [NGT] feeding), age at onset, motor performance (walking age, maximal motor ability, age when wheelchair use commenced and at loss of ambulation), respiratory involvement (nocturnal/daily noninvasive ventilation [NNIV/DNIV], invasive ventilation), cardiac and bulbar involvement (gastrostomy/jejunostomy [G/J] insertion), orthopedic complications (hip dysplasia, ankle contractures, scoliosis), other features (cognitive impairment, undescended testis/orchidopexy, malignant hyperthermia reactions), and survival.
Standard protocol approvals, registrations, and patient consents. Parents/guardians provided written informed consent for the diagnostic genetic analysis, according to the Great Ormond Street Hospital guidance. This study was approved by the West London & GTAC Ethics Committee (08/H0707/119).
Genetic analysis. Genomic DNA was extracted from peripheral blood leukocytes according to standard procedures. Genetic analyses were performed according to the histologic/clinical phenotype, depending on the tests available at the time. Most genes were screened by PCR amplification and Sanger sequencing of coding exons: skeletal muscle a-actin (ACTA1), myotubularin (MTM1), selenoprotein N (SEPN1), b-tropomyosin (TPM2), tropomyosin 3 (TPM3), dynamin 2 (DNM2), ryanodine receptor type 1 (RYR1), cofilin 2 (CFL2), troponin T (TNNT1), amphiphysin 2 (BIN1), and kelch-like family member 40 (KLHL40). In 3 patients, only mutational hotspots of RYR1 were sequenced. Intragenic and flanking microsatellite markers were used to indicate linkage to the nebulin (NEB) gene. A breakpoint PCR assay was used to detect the common exon 55 deletion mutation of NEB. 20 In 2 cases, next-generation sequencing analysis has subsequently allowed comprehensive analysis of NEB. 21 Histologic analysis. Muscle biopsies were reviewed and classified according to criteria suggested by Dubowitz et al. 22 : (1) nemaline myopathy (NM); (2) centronuclear myopathy (CNM); (3) "core myopathies," including central core disease and multiminicore disease; (4) FTD; (5) type 1 fiber predominance/ uniformity; and (6) nonspecific myopathic changes (NSMC).
Statistical analysis. Descriptive statistics used were mean, median, and SD. Kaplan-Meier curve was performed using GraphPad Prism 5 software (GraphPad Software, La Jolla, CA).
RESULTS
One hundred twenty-five patients according to the above criteria were included; 64 of the 125 were females (51.2%) and 61 were males (48.8%). Mean age at last follow-up was 10.5 years (median 10 years, SD 7.72), ranging from the neonatal period to 47 years, because a few selected cases were followed into adulthood (18/125, 14.4%). A genetic diagnosis was established in 99 of 125 (79.2%), with the following genetic backgrounds identified: RYR1 in 44 of 97 (44.4%), of whom 23 (23.2%) had autosomal recessive (AR) and 21 (21.2%) autosomal dominant (AD) inheritance; ACTA1 in 17 of 99 (17.2%); SEPN1 in 16 of 99 (16.2%); NEB in 8 of 99 (8.1%); MTM1 in 8 of 99 (8.1%); TPM3 and KLHL40 both in 2 of 99 (2.1%); and TPM2 and DNM2 both in 1 of 99 (1%). A muscle biopsy was performed in 104 of 125 (83.2%): the most common diagnosis was core myopathy (39/104, 37.5%), followed by NM (33/104, 31.8%), CNM (18/104, 17.3%), FTD and type 1 fiber predominance/uniformity (both with 5/104, 4.8%), and NSMC (4/104, 3.8%) (figure e-1 on the Neurology ® Web site at Neurology.org). All cases presenting with NSMC were genetically characterized and due to SEPN1 mutations. Figure e-2 illustrates histologic features associated with different genetic backgrounds. Clinical information is summarized below with more detail provided in e-Results. Tables e-1 and e-2 summarize clinical information and genetic background, respectively, of each case.
Family history. Consanguinity was present in 20 of 125 families (16%). There was a history of spontaneous miscarriages in 9 of 125 (7.2%), mainly in families with AD RYR1 mutations (4/9). Premature death in family members was reported in 8 of 125 (6.4%), mainly in the subset with MTM1 mutations (3/8). Thirty-nine of 125 (31.2%) had at least one affected living relative. Among patients with confirmed genetic diagnosis, the most common family ancestry was Caucasian-British (58/99, 58.5%), followed by families of Pakistani origin (14/99, 14.1%). Only 2 cases originated from Arab countries. Within the group of CMs with AR inheritance (50 patients), 22 of 50 patients (44%) had Caucasian-British ancestors and were mainly compound heterozygous for RYR1 mutations (12 cases), whereas 12 of 50 patients (24%) had Pakistani parents and carried mainly homozygous mutations in SEPN1 (5 cases) or NEB (4 cases). Consanguinity was reported in 2 of 50 Caucasian-British families (4%) and in 8 of 50 Pakistani families (16%), a likely explanation for the highest prevalence of homozygous mutations in the latter ethnic subgroup. Within the group of CMs with AD inheritance (49 patients), 36 of 49 (73%) were of Caucasian-British descent and carried mainly heterozygous dominant RYR1 (17 cases) or ACTA1 (11 cases) mutations. Within the subgroup of Pakistani descent, there was no case with dominantly inherited and only one case with recessively inherited RYR1-related myopathy.
Perinatal history and age at onset. Antenatal onset was evidenced by frequently reduced fetal movements (47/125, 37.6%) and/or polyhydramnios (29/125, 23.2%) (figures 1 and 2A). The prematurity rate was increased (23/110, 21.1%). 23 Neonatal bulbar and respiratory involvement requiring tube feeding (32/125, 25.6%) and ventilatory support (38/125, 30.4%) were common.
Mobility and best motor abilities. Eighty-nine of 120 patients (74.1%), where this information was available, achieved independent ambulation (see figure 3 ). Eight of 89 patients (9%), who initially acquired independent ambulation, became wheelchair-dependent at a mean age of 10.1 years (median 9.5 years, SD 2.69), irrespective of the genetic background: all were late to walk and no one achieved a full range of gross motor abilities.
Respiratory involvement. Eighty of 125 (64.1%) had highly variable respiratory involvement, ranging from patients needing neonatal respiratory support (38/125, 30 .4%) to those having recurrent chest infections (51/ 128, 40%) and/or decreased forced vital capacity (,60%) (51/125, 40.8%). Figure 4 shows NNIV provision due to nocturnal hypoventilation. Permanent tracheostomy and also diurnal ventilation (DNIV) were required, respectively, in 4 of 125 (3.2%) and 6 of 125 patients (4.8%), without consistent genotypephenotype correlations.
Bulbar impairment. Fifty-eight of 125 (46.4%) had bulbar impairment, and figure 4 illustrates the proportion requiring G/J insertion. Seven patients in whom neonatal NGT was required died in their first months, without undergoing any feeding tube placement because of marked respiratory impairment. Among the surviving patients requiring NGT at birth, all underwent subsequent G/J placement, but 4 patients affected by RYR1-related myopathy (2 with AR, 2 with AD inheritance) improved to an extent that this became unnecessary. In 11 patients who did not require neonatal NGT, G/J was placed because of subsequent failure to thrive (height/weight less than third percentile). Perinatal features (A) Antenatal history: the highest percentage of decreased FM and polyhydramnios was found in MTM1-related myopathy. (B) Age at birth: the overall prematurity rate in our cohort of CMs (21.1%) was higher than in the general population of England and Wales (7.4% in 2008). 23 MTM1 patients universally had severe neonatal onset requiring respiratory (8/8) and feeding (7/8) support. Neonatal complications were anticipated in a high proportion of pregnancies with decreased fetal movements (6/8, 75%) and polyhydramnios (4/8, 50%); the latter feature probably also responsible for the high percentage of preterm deliveries (5/8, 62.5%), contributing to a more severe course. All 3 long-term survivors were wheelchair-dependent and ventilated: patients 30 and 33 on NNIV and patient 32 on DNIV; the latter was also the only patient with severe learning difficulties and focal epilepsy in our cohort.
Within the RYR1 group, neonatal onset was more frequent in AR compared with AD cases (12/23, 52.2%, and 5/21, 23.8%, respectively), with an increased occurrence of neonatal complications in the AR subset. Bulbar and respiratory involvement was more frequently observed in the AR subgroup, where 8 of 23 (34.8%) underwent G/J (p 5 0.0028, x 2 test) and 3 of 23 (13.4%) required NNIV; this was not a feature in AD cases. Motor abilities were comparable in both subgroups: 17 of 21 AD (81%) and 18 of 22 AR patients (82%) achieved independent ambulation; 10 of 17 AD (58.8%) and 11 of 18 AR patients (67.1%) had walking delay. Six of 44 ambulant patients (13.6%) became wheelchairdependent (4 with AR inheritance, 2 with AD). No patient required DNIV and tracheostomy in either subset. Lethal cases were not observed. ACTA1 and NEB were the genes most frequently implicated in NM. All ACTA1 mutations were de novo dominant with the exception of patient 14 with a homozygous recessive mutation inherited from asymptomatic parents, and patient 13 who carried the same dominant mutation as her mildly affected mother. Neonatal onset was the main presentation in both subgroups, but ACTA1 patients had a higher rate of neonatal complications compared with NEB. All NEB cases acquired independent ambulation, while motor abilities of patients with the ACTA1 mutation were more variable, with 10 of 15 (66.74%) achieving independent ambulation. Patient 8 was the only patient with the ACTA1 mutation who became wheelchair-dependent, whereas patient 25, with the NEB mutation, was using a wheelchair outdoors at 14 years of age. Both G/J and NNIV were required in about half of cases and at a similar age: NNIV was started in patients with ACTA1 mutation at a mean age of 8.5 years (median 2.5 years, SD 11.36) and in patients with NEB mutation at a mean age of 7.3 years (median 6.5 years, SD 4.3); G/J was placed in patients with ACTA1 mutation at a mean age of 2.8 years (median 1 year, SD 4.14) and in patients with NEB mutation at a mean age of 5.4 years (median 2.65 years, SD 7.03). In NEB cases, G/J was never preceded by NGT placement, because failure to thrive rather than feeding difficulties was the main feature, whereas in most ACTA1 patients, neonatal swallowing dysfunction was observed.
All SEPN1 patients presented beyond the neonatal period; the only 2 cases with onset in the second decade both had SEPN1 mutations. All SEPN1 cases achieved independent ambulation, mainly before 18 months. Patients with the SEPN1 mutation had the highest prevalence of scoliosis and NNIV requirement. Four of 16 cases (25%), all with restrictive respiratory impairment requiring NNIV, showed right ventricle impairment and pulmonary hypertension. DISCUSSION CMs are rare neuromuscular conditions with distinct histologic and clinical features, and multiple genetic backgrounds. 1, 3, 12 Longitudinal studies outlining frequency of complications and progression over time are scarce. Here, we delineate the natural history of a large cohort of CM cases. Most patients had a genetic diagnosis, with core myopathies and RYR1 mutations, respectively, the most common histopathologic and genetic diagnoses, as reported. 11, 13, 25 Bearing in mind that the defining features of the CMs (such as FTD, nemaline rods, cores, and central nuclei) are not specific and may occur in other clinical situations, 26 including CNS developmental malformations 27 and recently recognized multisystem disorders with primary autophagy defects, 28, 29 we took great care that only patients with clinicopathologic features of a CM without evidence of other underlying conditions were included in this study. The onset of clinical signs was observed predominantly within the first year of life: approximately half of the patients presented in the neonatal period with severe feeding and respiratory complications, as described. [1] [2] [3] [13] [14] [15] 19 Neonatal presentation was more frequently preceded by pregnancy complications, including polyhydramnios and preterm deliveries, compared with a previous study in which only a few neonates were included. 30 Although lethal outcome for a few specific conditions has been reported, 15, 17, 19, 26, 27 the relative mortality rate of different CM subgroups has not been investigated. In our cohort, 12% of patients died, predominantly within the first year of life. The high mortality of X-linked myotubular myopathy 18 was confirmed, together with the lethality of severe congenital NM. 19 All deceased patients had profound respiratory impairment, with respiratory infections often the precipitating event in neonates/infants with respiratory involvement, highlighting the need for early recognition of infections, timely institution of treatment, and consideration of ventilatory support as part of a proactive management plan. 31 Although CMs are considered essentially static conditions, the clinical course may be progressive. In particular, failure to thrive and insidious respiratory insufficiency beyond the first year were observed in a substantial proportion, as reported in smaller series. 5, [13] [14] [15] 19 It is often thought that children with CMs who achieve independent ambulation usually do not lose this ability later. 4 However, intermittent wheelchair use was needed in 22% of our ambulant patients, whereas 9% became completely wheelchairdependent within a few years, supporting observations of deterioration in muscle strength after the achievement of ambulation. 32 All patients who lost ambulation were late walkers; this may suggest that ambulatory loss reflects the additional effects of increased height/weight on already substantially compromised muscle power, rather than a progressive loss of muscle strength.
The prevalence of orthopedic complications, in particular scoliosis, has not been extensively investigated in CMs. 5, 33 We demonstrated that early-onset scoliosis is common, but usually mild and needing surgery only in 13.6% of all CMs. Half of all patients with scoliosis were ambulant at the time of surgery, suggesting that the development of scoliosis is more determined by early and disproportionate axial weakness 1, 3, 13 rather than ambulatory state. Scoliosis surgery was overall well tolerated, with preoperative motor abilities and respiratory performance maintained. There were no perioperative deaths, probably reflecting the absence of severe cardiac involvement. Indeed, cardiac involvement was rare, mainly right ventricle involvement associated with restrictive pulmonary impairment in SEPN1-mutated cases. 5, 34 A relatively high incidence of talipes was observed mainly among patients with NM, most often with NEB mutation, reflecting distal involvement and genetic overlap between the NM and the distal arthrogryposis spectrum.
We identified consistent genotype-phenotype correlations of relevance to clinical practice. At the severe end of the spectrum, dramatic neonatal onset with bulbar and respiratory complications was observed in all patients with MTM1 mutation, 18 but also in several patients with ACTA1 mutation, 35, 36 a few RYR1 cases, mainly with recessive inheritance, 17, 37 and some patients with KLHL40 mutation. 38 Despite severe neonatal onset in some cases, all patients with RYR1 mutation survived, in keeping with only a few lethal cases previously reported in the literature. 17,39,40,e1 We found that in RYR1-related myopathies, feeding difficulties can be transitory: the only 4 neonates in our cohort who were tube-fed, but did not subsequently require G/J placement, all had RYR1 mutations. In 2 additional patients with RYR1 mutation, gastrostomy insertion performed early in life was subsequently removed because of spontaneous swallowing improvement and/or improved weight gain. Whereas respiratory support at birth may be needed in a proportion of RYR1 patients, NNIV requirement over the following years is not a feature. Taken together, those data suggest an overall more benign course of congenital RYR1-related myopathies regarding bulbar complications and survival, in keeping with smaller studies. 13,e2,e3 Within NMs, patients with NEB mutations are thought to be more mildly affected than those with ACTA1 mutations, 15 although rare case reports have suggested a lethal course in patients with NEB mutations, e4 as well as much milder and adult phenotypes of ACTA1. 8 Of note, in our cohort, ACTA1 and NEB subgroups required NNIV and G/J in similar proportion, highlighting that, with the exception of early lethal ACTA1 cases, bulbar and respiratory complications are comparable over time. Those findings are in contrast to a recent smaller survey 13 in which patients with ACTA1 mutation most frequently required G/J insertion, probably because of a shorter period of observation.
In conclusion, our study expands the clinical spectrum of CMs, assesses the overall mortality, and suggests a certain decline of motor function particularly in the subset in which independent ambulation could only be achieved with difficulty. We provide valuable information for counseling according to genotype, and to improve management plans. Data were not prospectively collected, and only 14.4% of patients were adults at the last follow-up, which could be a limitation. This highlights the need for further prospective studies, including adults, focusing on validation of functional measures for CMs that may be useful for clinical trials.
